2017 FDA Peptide Harvest
College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa
School of Chemistry, University of KwaZulu-Natal, Durban 4001, South Africa
KRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, University of Barcelona, 08028 Barcelona, Spain
Department of Organic Chemistry, University of Barcelona, 08028 Barcelona, Spain
These authors contributed equally to this work.
Authors to whom correspondence should be addressed.
Received: 9 April 2018 / Revised: 30 April 2018 / Accepted: 3 May 2018 / Published: 7 May 2018
2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action.
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Al Musaimi, O.; Al Shaer, D.; de la Torre, B.G.; Albericio, F. 2017 FDA Peptide Harvest. Pharmaceuticals 2018, 11, 42.
Al Musaimi O, Al Shaer D, de la Torre BG, Albericio F. 2017 FDA Peptide Harvest. Pharmaceuticals. 2018; 11(2):42.
Al Musaimi, Othman; Al Shaer, Danah; de la Torre, Beatriz G.; Albericio, Fernando. 2018. "2017 FDA Peptide Harvest." Pharmaceuticals 11, no. 2: 42.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.